DE69937060D1 - Immunogene zusammensetzungen und deren verwendungen - Google Patents
Immunogene zusammensetzungen und deren verwendungenInfo
- Publication number
- DE69937060D1 DE69937060D1 DE69937060T DE69937060T DE69937060D1 DE 69937060 D1 DE69937060 D1 DE 69937060D1 DE 69937060 T DE69937060 T DE 69937060T DE 69937060 T DE69937060 T DE 69937060T DE 69937060 D1 DE69937060 D1 DE 69937060D1
- Authority
- DE
- Germany
- Prior art keywords
- immunogenic compositions
- immunogenic
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP5893A AUPP589398A0 (en) | 1998-09-14 | 1998-09-14 | Immunogenic compositions and uses thereof |
PCT/AU1999/000770 WO2000015254A1 (en) | 1998-09-14 | 1999-09-14 | Immunogenic compositions and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69937060D1 true DE69937060D1 (de) | 2007-10-18 |
Family
ID=3810114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69937060T Expired - Lifetime DE69937060D1 (de) | 1998-09-14 | 1999-09-14 | Immunogene zusammensetzungen und deren verwendungen |
Country Status (5)
Country | Link |
---|---|
US (3) | US7575755B1 (de) |
EP (1) | EP1113815B1 (de) |
AU (1) | AUPP589398A0 (de) |
DE (1) | DE69937060D1 (de) |
WO (1) | WO2000015254A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1808443A1 (de) * | 2006-01-13 | 2007-07-18 | Institut Pasteur | Gereinigtes Polypeptid beinhaltend oder bestehend aus einem C-terminalen MSP1 Antigen von Plasmodium falciparum das eine Glycosylphosphatidylinositol-Gruppe (GPI) trägt |
US8188213B2 (en) | 1996-02-14 | 2012-05-29 | Institut Pasteur | Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI) |
AUPP589398A0 (en) * | 1998-09-14 | 1998-10-08 | Walter And Eliza Hall Institute Of Medical Research, The | Immunogenic compositions and uses thereof |
AUPP675898A0 (en) * | 1998-10-27 | 1998-11-19 | Walter And Eliza Hall Institute Of Medical Research, The | A method of activating t cells and agents useful for same |
EP1171157B1 (de) * | 1999-04-22 | 2006-08-09 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Verwendung von glukose-6-phosphate-isomerase und dagegen gerichteten antikörpern zur diagnose und therapeutischen behandlung von arthritis, und test von zur behandlung der arthritis wirksamen verbindungen |
US7033745B1 (en) | 1999-04-22 | 2006-04-25 | Institut National De La Sante Et De La Rescherche Medicale (Inserm) | Use of gluclose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
US6939857B2 (en) | 2000-05-12 | 2005-09-06 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
US6716826B2 (en) | 2000-05-12 | 2004-04-06 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
US6953781B2 (en) | 2000-05-12 | 2005-10-11 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
US6759390B2 (en) | 2000-05-12 | 2004-07-06 | Manuel Martin-Lomas | Compounds and their uses |
ATE390434T1 (de) * | 2000-05-12 | 2008-04-15 | Rodaris Pharmaceuticals Ltd | Inositolphosphoglycanderivate und ihre medizinische verwendung |
HUE025624T2 (en) * | 2002-07-26 | 2016-04-28 | The Walter And Eliza Hall Inst Of Medical Res | Immunogenic preparations and diagnostic and therapeutic use |
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
WO2005120519A1 (en) * | 2004-06-10 | 2005-12-22 | The Walter And Eliza Hall Institute Of Medical Research | Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors |
WO2017075053A1 (en) * | 2015-10-26 | 2017-05-04 | Cour Pharmaceuticals Development Company Inc. | Immune-modifying particles for the treatment of malaria |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9203039D0 (en) * | 1992-02-13 | 1992-03-25 | Univ London | Treatment |
DE4311580C1 (de) * | 1993-04-12 | 1994-08-18 | Werner Prof Dr Med Reutter | Glycoproteine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel |
US6113917A (en) * | 1995-04-25 | 2000-09-05 | Rmf Dictagene S.A. | Modified polypeptides for enhanced immunogenicity |
EP0850244B1 (de) * | 1995-09-15 | 2002-07-31 | Organon Teknika B.V. | Toxoplasma gondii glykokonjugate |
WO1997026911A1 (en) * | 1996-01-29 | 1997-07-31 | Georgetown University | Malaria vaccine based upon the addition of a msa1 peptide |
US7968689B2 (en) * | 1997-03-07 | 2011-06-28 | Human Genome Sciences, Inc. | Antibodies to HSDEK49 polypeptides |
US5968742A (en) * | 1997-05-22 | 1999-10-19 | Incyte Pharmaceuticals, Inc. | Human GPI2 homolog |
US20070014787A1 (en) * | 1998-07-15 | 2007-01-18 | Human Genome Sciences, Inc. | 71 human secreted proteins |
AUPP589398A0 (en) * | 1998-09-14 | 1998-10-08 | Walter And Eliza Hall Institute Of Medical Research, The | Immunogenic compositions and uses thereof |
AUPP675898A0 (en) * | 1998-10-27 | 1998-11-19 | Walter And Eliza Hall Institute Of Medical Research, The | A method of activating t cells and agents useful for same |
WO2004005532A2 (en) * | 2002-07-10 | 2004-01-15 | Massachusetts Institute Of Technology | Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans |
HUE025624T2 (en) * | 2002-07-26 | 2016-04-28 | The Walter And Eliza Hall Inst Of Medical Res | Immunogenic preparations and diagnostic and therapeutic use |
US7393534B2 (en) * | 2003-07-15 | 2008-07-01 | Barros Research Institute | Compositions and methods for immunotherapy of cancer and infectious diseases |
WO2005120519A1 (en) * | 2004-06-10 | 2005-12-22 | The Walter And Eliza Hall Institute Of Medical Research | Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors |
US7928077B2 (en) * | 2008-07-11 | 2011-04-19 | Academia Sinica | Alpha-galactosyl ceramide analogs and their use as immunotherapies |
-
1998
- 1998-09-14 AU AUPP5893A patent/AUPP589398A0/en not_active Abandoned
-
1999
- 1999-09-14 WO PCT/AU1999/000770 patent/WO2000015254A1/en active IP Right Grant
- 1999-09-14 US US09/787,111 patent/US7575755B1/en not_active Expired - Fee Related
- 1999-09-14 DE DE69937060T patent/DE69937060D1/de not_active Expired - Lifetime
- 1999-09-14 EP EP99945777A patent/EP1113815B1/de not_active Expired - Lifetime
-
2009
- 2009-07-13 US US12/501,859 patent/US8058401B2/en not_active Expired - Fee Related
-
2011
- 2011-10-07 US US13/269,238 patent/US8470343B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US8058401B2 (en) | 2011-11-15 |
US8470343B2 (en) | 2013-06-25 |
US7575755B1 (en) | 2009-08-18 |
EP1113815B1 (de) | 2007-09-05 |
US20120034241A1 (en) | 2012-02-09 |
EP1113815A1 (de) | 2001-07-11 |
AUPP589398A0 (en) | 1998-10-08 |
WO2000015254A1 (en) | 2000-03-23 |
EP1113815A4 (de) | 2002-11-06 |
US20090275737A1 (en) | 2009-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69918233D1 (de) | Polymilchsäure zusammensetzung und daraus hergestellter film | |
DE69933544D1 (de) | Polymer und härtbare zusammensetzung | |
DE69918871D1 (de) | Zementzusatzmittel und Zementzusammensetzung | |
DE60025147D1 (de) | Kosmetische Zusammensetzung und Verwendungen | |
NO20005913L (no) | Legemiddelsammensetning | |
NO20022334L (no) | Ny sammensetning og anvendelse | |
NO20004758L (no) | Vaksinesammensetning | |
DE69923359D1 (de) | Zusammensetzungen und daraus hergestellte gegenstände | |
ID26186A (id) | Komposisi sampo | |
ID28694A (id) | Komposisi sampo | |
DE69915066D1 (de) | Biozide zusammensetzung und deren verwendung | |
ID29430A (id) | Komposisi herbisida | |
PT1139761E (pt) | Composicoes herbicidas e concentrados tensioactivos | |
DE69823804D1 (de) | Azeotrope methoxyperfluorpropanzusammensetzungen und deren verwendung | |
DE60130834D1 (de) | Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung | |
LV12624A (lv) | Thienylazolylalcoxyethanamines their preparation and their application as medicaments | |
IL148247A (en) | Vaccine and its uses | |
DE60033043D1 (de) | Modifizierte pflanzenviren und deren verwendungsmethoden | |
DE60022828D1 (de) | Kosmetikeinheit und deren Zusammensetzung | |
DE69937060D1 (de) | Immunogene zusammensetzungen und deren verwendungen | |
DE69724629D1 (de) | Zusammensetzungen und deren verwendungen | |
DE69902473D1 (de) | Kosmetikzusammensetzung | |
DE69919549D1 (de) | Sauerstoffabsorbierende zusammensetzung und ihre anwendungsmethode | |
DE69724367D1 (de) | Polyarylensulfid und zusammensetzung | |
DE60005514D1 (de) | Dormanz-brechende zusammenstezung und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |